drugset / Trial / NCT05767060
BAT7104 Injection in Patients With Advanced Malignant Tumors.
Non-randomizedSequentialQuadruple-blindTreatment
Summary
A multi-center, open phase Ia/Ib clinical study to evaluate the safety, tolerance, pharmacokinetics and preliminary clinical efficacy of BAT7104 injection in patients with advanced malignant tumors.
Timeline
- Start
- 2022-01-20
- Primary completion
- 2024-12-11
- Completion
- 2024-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BAT7104 | Unknown | 0.1 mg/kg | Intravenous |
| Subject | BAT7104 | Unknown | 0.3 mg/kg | Intravenous |
| Subject | BAT7104 | Unknown | 1 mg/kg | Intravenous |
| Subject | BAT7104 | Unknown | 3 mg/kg | Intravenous |
| Subject | BAT7104 | Unknown | 10 mg/kg | Intravenous |
| Subject | BAT7104 | Unknown | 20 mg/kg | Intravenous |
| Subject | BAT7104 | Unknown | 40 mg/kg | Intravenous |